Prospective observational study II on the prognosis of patients with unresectable advanced gastroenteral and pancreatic neuroendocrine tumors in Japa

Not Applicable

• Conditions: unresectable advanced gastroenteral and pancreatic neuroendocrine tumors

• Registration Number: JPRN-UMIN000015976
• Lead Sponsor: Foundation for Biomedical Research and Innovation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-12-17
• Study Completion: 2020-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 186

Inclusion Criteria

Not provided

Exclusion Criteria

1) previously treatment of NET excent for curative resection, neoadjuvant therapy or adjuvant therapy within 1 year before the diagnosis of unresectable NET or reccurent one after curative resection 2) concurrent multiple malignancies 3) resectable reccurent NET after curative resection 4) previously enrolled subject 5)Patients regarded as ineligible for other reason by the investigator.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
overall survival

Secondary Outcome Measures

Name	Time	Method
progression-free survival